Is Drugs Made In America Acquisition II Corp. Ordinary Shares overvalued?

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — key valuation metrics and fundamentals.

No verdict

Price

$10.13

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$645.3M

Dividend yield

0.0%

Return on equity

2.3%

Sector

Financial Services

Fair value compares DMII's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks